The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs ...

Analyst Michael Ulz from Morgan Stanley reiterated a Buy rating on Dyne Therapeutics (DYN – Research Report) and keeping the price target ...

Continuous research has led to new drug developments, particularly disease-modifying therapies (DMTs) that slow MS progression. Monoclonal antibodies, oral therapies, and infusion treatments are among ...

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug DetectionFDA 510(k) Clearance ...